Spots Global Cancer Trial Database for acute myeloid leukemia with multilineage dysplasia
Every month we try and update this database with for acute myeloid leukemia with multilineage dysplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome | NCT03047993 | Acute Myeloid L... Blasts 20-30 Pe... Blasts 20-30 Pe... Chronic Myelomo... High Risk Myelo... IPSS Risk Categ... Myelodysplastic... | Azacitidine Glutaminase Inh... | 18 Years - | M.D. Anderson Cancer Center | |
| Biocollection in MyeloDysplastic Syndrome (P-MDS) | NCT04869683 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Myelodysplastic... Acute Myeloid L... Chromosome Abno... | description of ... | 18 Years - | University Hospital, Brest | |
| Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | NCT01567059 | Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Secondary Acute... Secondary Myelo... Untreated Adult... | tosedostat cytarabine decitabine | 18 Years - | Fred Hutchinson Cancer Center | |
| Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | NCT01567059 | Acute Myeloid L... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Secondary Acute... Secondary Myelo... Untreated Adult... | tosedostat cytarabine decitabine | 18 Years - | Fred Hutchinson Cancer Center | |
| Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes | NCT04802161 | Acute Myeloid L... Acute Myeloid L... Acute Myeloid L... Chronic Myelomo... Myelodysplastic... Myeloproliferat... | Biospecimen Col... Bone Marrow Asp... Liposome-encaps... Pomalidomide | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia | NCT02658487 | Acute Myeloid L... Acute Myeloid L... Acute Myeloid L... Myeloid Sarcoma Secondary Acute... Therapy-Related... Therapy-Related... | Cytarabine Vosaroxin | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome | NCT03047993 | Acute Myeloid L... Blasts 20-30 Pe... Blasts 20-30 Pe... Chronic Myelomo... High Risk Myelo... IPSS Risk Categ... Myelodysplastic... | Azacitidine Glutaminase Inh... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
